2-219420915-C-T
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PVS1PM2PP5
The NM_001927.4(DES):c.985C>T(p.Gln329*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000205 in 1,461,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001927.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DES | ENST00000373960.4 | c.985C>T | p.Gln329* | stop_gained | Exon 5 of 9 | 1 | NM_001927.4 | ENSP00000363071.3 | ||
DES | ENST00000477226.6 | n.459C>T | non_coding_transcript_exon_variant | Exon 4 of 8 | 4 | |||||
DES | ENST00000492726.1 | n.380C>T | non_coding_transcript_exon_variant | Exon 4 of 6 | 4 | |||||
DES | ENST00000683013.1 | n.373C>T | non_coding_transcript_exon_variant | Exon 3 of 7 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251050Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135728
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461356Hom.: 0 Cov.: 38 AF XY: 0.00000138 AC XY: 1AN XY: 726962
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Desmin-related myofibrillar myopathy Pathogenic:2
The p.Gln329X variant in DES has not been previously reported in individuals with desmin-related myopathy but has been reported in ClinVar (Variation ID: 520492). This variant has been identified in 1/113572 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org). This nonsense variant leads to a premature termination codon at position 329, which is predicted to lead to a truncated or absent protein. Heterozygous loss of function of the DES gene is an established disease mechanism in desmin-related myopathy. In summary, although additional studies are required to fully establish its clinical significance, the p.Gln329X variant is likely pathogenic. ACMG/AMP Criteria applied: PVS1, PM2. -
This sequence change creates a premature translational stop signal (p.Gln329*) in the DES gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DES are known to be pathogenic (PMID: 23575897). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with DES-related conditions. ClinVar contains an entry for this variant (Variation ID: 520492). For these reasons, this variant has been classified as Pathogenic. -
Cardiomyopathy Pathogenic:1
Variant summary: DES c.985C>T (p.Gln329X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been reported in affected individuals (HGMD). The variant allele was found at a frequency of 4e-06 in 251050 control chromosomes (gnomAD). To our knowledge, no occurrence of c.985C>T in individuals affected with Cardiomyopathy and no experimental evidence demonstrating its impact on protein function have been reported. Two ClinVar submitters have assessed the variant since 2014: both classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Arrhythmogenic right ventricular cardiomyopathy Pathogenic:1
- -
not provided Pathogenic:1
- -
Cardiovascular phenotype Uncertain:1
The p.Q329* variant (also known as c.985C>T), located in coding exon 5 of the DES gene, results from a C to T substitution at nucleotide position 985. This changes the amino acid from a glutamine to a stop codon within coding exon 5. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. Although biallelic loss of function alterations in DES have been associated with autosomal recessive DES-related myopathy, haploinsufficiency for DES has not been clearly established as a mechanism of disease for autosomal dominant DES-related myopathy. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at